Showing results (961-970 of 1,055) with videos related to

Sort By:
Pageof 106
Journal of the American College of Cardiology|July 13, 2019
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver DiseaseArman Qamar, Elliott M Antman, Christian T Ruff, et al.
Scientific Reports|April 11, 2015
Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiationXinwei Wang, Liang Wei, Julie M Cramer, et al.
Radiation Research|September 24, 2011
GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell linesMark E Bernard, Hyun Kim, Hebist Berhane, et al.
Cancer Biology & Therapy|March 12, 2009
Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TKIsrael Hodish, Reshef Tal, Aviv Shaish, et al.
Free Radical Biology & Medicine|March 17, 2009
Cytochrome c/cardiolipin relations in mitochondria: a kiss of deathValerian E Kagan, Hülya A Bayir, Natalia A Belikova, et al.
Allergy and Asthma Proceedings|December 6, 2021
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocolGayatri B Patel, Krishan D Chhiba, Michael M Chen, et al.
Molecular Cancer Therapeutics|October 27, 2011
Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancerYixian Zhang, Stephen Castaneda, Melissa Dumble, et al.
Journal of the American Society of Nephrology : JASN|August 6, 2020
Successful Introduction of Human Renovascular Units into the Mammalian KidneyOren Pleniceanu, Orit Harari-Steinberg, Dorit Omer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2011
Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigatorsJean-Claude M Rwigema, Barbara Beck, Wei Wang, et al.
Journal of Medicinal Chemistry|August 10, 2001
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activityH R Tsou, N Mamuya, B D Johnson, et al.
Pageof 106